Contineum Therapeutics Inc. Class A Common Stock (CTNM) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Contineum Therapeutics In...

NASDAQ: CTNM · Real-Time Price · USD
11.35
0.60 (5.58%)
At close: Oct 03, 2025, 3:59 PM
11.13
-1.94%
After-hours: Oct 03, 2025, 04:22 PM EDT

Contineum Therapeutics Class A Common Stock Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
21.94M 15.53M 5.57M 4.63M
Short-Term Investments
182.82M 109.66M 41.67M 64.37M
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
3K 1.28M 129K 97K
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
1.63M 2.52M 1.15M 775K
Total Current Assets
206.39M 127.71M 48.39M 69.78M
Property-Plant & Equipment
6.46M 1.4M 2.12M 642K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
6.46M 2.68M 2.24M 739K
Total Assets
212.85M 130.39M 50.64M 70.52M
Account Payables
1.81M 635K 430K 660K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a 3.95M 1.25M
Other Current Liabilities
3.34M 2.48M 752K 1.01M
Total Current Liabilities
9.97M 5.48M 7.55M 3.67M
Long-Term Debt
n/a 192.62M 132.48M 3.66M
Other Long-Term Liabilities
n/a 110K 3.02M 134.08M
Total Long-Term Liabilities
4.81M 192.84M 136.3M 137.74M
Total Liabilities
14.78M 198.32M 143.85M 141.41M
Total Debt
6.26M 193.19M 138.33M 4.91M
Book Value
198.07M -67.94M -93.21M -70.89M
Book Value Per Share
10.23 -2.69 -3.71 -2.82
Common Stock
26K 2K 12K 12K
Retained Earnings
-117.4M -75.14M -97.86M -73.61M
Comprehensive Income
71K 108K -76K -35K
Shareholders Equity
198.07M -67.94M -93.21M -70.89M
Total Investments
182.82M 109.66M 41.67M 64.37M